Alpine Immune Sciences Inc (ALPN)
64.96
-0.01
(-0.02%)
USD |
NASDAQ |
May 16, 16:00
64.96
0.00 (0.00%)
After-Hours: 18:04
Alpine Immune Sciences Price to Book Value: 13.39 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 13.40 |
| May 14, 2024 | 13.39 |
| May 13, 2024 | 13.39 |
| May 10, 2024 | 13.39 |
| May 09, 2024 | 13.36 |
| May 08, 2024 | 13.34 |
| May 07, 2024 | 13.33 |
| May 06, 2024 | 13.32 |
| May 03, 2024 | 13.32 |
| May 02, 2024 | 13.32 |
| May 01, 2024 | 12.73 |
| April 30, 2024 | 12.73 |
| April 29, 2024 | 12.75 |
| April 26, 2024 | 12.72 |
| April 25, 2024 | 12.73 |
| April 24, 2024 | 12.72 |
| April 23, 2024 | 12.72 |
| April 22, 2024 | 12.73 |
| April 19, 2024 | 12.72 |
| April 18, 2024 | 12.70 |
| April 17, 2024 | 12.70 |
| April 16, 2024 | 12.71 |
| April 15, 2024 | 12.69 |
| April 12, 2024 | 12.68 |
| April 11, 2024 | 12.69 |
| Date | Value |
|---|---|
| April 10, 2024 | 9.269 |
| April 09, 2024 | 7.673 |
| April 08, 2024 | 7.592 |
| April 05, 2024 | 6.878 |
| April 04, 2024 | 6.961 |
| April 03, 2024 | 7.509 |
| April 02, 2024 | 7.726 |
| April 01, 2024 | 7.924 |
| March 31, 2024 | |
| March 28, 2024 | 7.923 |
| March 27, 2024 | 7.725 |
| March 26, 2024 | 7.485 |
| March 25, 2024 | 7.505 |
| March 22, 2024 | 7.863 |
| March 21, 2024 | 8.315 |
| March 20, 2024 | 8.041 |
| March 19, 2024 | 7.985 |
| March 18, 2024 | 7.089 |
| March 15, 2024 | 7.271 |
| March 14, 2024 | 7.173 |
| March 13, 2024 | 7.317 |
| March 12, 2024 | 7.285 |
| March 11, 2024 | 7.072 |
| March 08, 2024 | 7.181 |
| March 07, 2024 | 7.395 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.307
Minimum
Nov 12 2019
16.86
Maximum
Jul 31 2020
3.837
Average
2.781
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 6.132 |
| Eliem Therapeutics Inc | 2.110 |
| Regeneron Pharmaceuticals Inc | 3.950 |
| Vera Therapeutics Inc | 6.494 |
| Eyenovia Inc | 4.323 |
Price to Book Value Related Metrics
| PS Ratio | 62.19 |
| Price | 64.96 |
| Earnings Yield | -0.99% |
| Market Cap | 4.456B |